Evidence map›Paper›PMID 33499822›Full record

ArticleBMC public health2021

The Association of Metabolic Syndrome with the development of cardiovascular disease among Kazakhs in remote rural areas of Xinjiang, China: a cohort study.

Wenwen Yang, Shuxia Guo, Haixia Wang, Yu Li, Xianghui Zhang, Yunhua Hu, Heng Guo, Kui Wang, Yizhong Yan, Jingyu Zhang and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. A Longitudinal Assessment of Metabolic Syndrome.Journal of clinical medicine · 2025
    Article
  3. Cardiovascular Risk Factors in China.Journal of geriatric cardiology : JGC · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Wenwen Yang *Department of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Shuxia Guo *Department of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Haixia WangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Yu LiDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Xianghui ZhangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Yunhua HuDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Heng GuoDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Kui WangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Yizhong YanDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Jingyu ZhangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Jiaolong MaDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Lei MaoDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Lati MuDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Jiaming LiuDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Yanpeng SongDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Changjing LiDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Zhuo MaDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.
Rulin MaDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China. marulin@126.com.
Jia HeDepartment of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China. hejia123.shihezi@163.com.
Shihezi University · CN

Funding

National Natural Science Foundation of China 81560551
6 · The paper itself

Abstract

backgroundMetabolic syndrome (MS) can promote the development of cardiovascular disease (CVD). The objective of this study was to examine the association of MS and its components with CVD, to further prevent and control CVD in Kazakhs.

methodsIn the cohort study, a total of 2644 participants completed the baseline survey between April 2010 and December 2012.The follow-up survey was conducted from April 2016 to December 2016 and was completed by 2286 participants (86.46% follow-up rate). Cox regression was used to evaluate the association of each component and the number of combinations of MS components on the development of CVD.

resultsA total of 278 CVD patients were enrolled from rural residents of Xinjiang. The average age of the MS and non-MS groups was 46.33 and 38.71 years, respectively. Independent associations with CVD were found for elevated blood pressure (BP) (adjusted hazard ratio (HR) [aHR] = 1.50,95%confidence interval [CI]: 1.08-2.08), elevated waist circumference (WC) (aHR = 1.60, 95%CI: 1.19-2.15), and elevated triglycerides (TG) (aHR = 1.44, 95%CI: 1.04-2.01). Participants with one to 5 MS components had an increased HR for developing CVD, from 1.82to 8.59 (P for trend < 0.001), compared with those with no MS components. The risk of developing CVD increased when TG and WC coexisted (aHR = 2.16, 95%CI: 1.54-3.04)), when TG and BP coexisted ((aHR = 1.92, 95%CI: 1.32-2.79), and when WC and BP coexisted (aHR = 1.93, 95%CI: 1.33-2.82)). However, no significant interactions were found between BP, WC, and TG.

conclusionsElevations of BP, WC, and TG were independent risk factors for CVD in Kazakhs. Control of these factors is important to prevent CVD in this population.

Indexed as

Cardiovascular DiseasesMetabolic SyndromeChinaCohort StudiesHumansRisk FactorsWaist CircumferenceCardiovascular diseaseKazakhsMetabolic syndrome

Identifiers

PMID33499822
PMCPMC7836449
OpenAlexW3122517002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.